Baird is out defending Incyte (INCY -1.9%) today after the company announced the departure of...
Thursday, August 30, 2012, 1:34 PM ETBaird is out defending Incyte (INCY -1.9%) today after the company announced the departure of its Chief Commercial Officer yesterday. The firm notes that while being less than a year into its first product launch may not the ideal time for a change, it's comfortable that it isn't any performance-related issue, and the company can manage the transition with minimal disruption. INCY management says the move has nothing to do with the launch trajectory - which is most important to investors.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles